Markets Geek

This toggle bar can feature specific pinned articles perhaps

Johnson & Johnson Stock Price Remains Close to All-Time Highs Ahead of Q3 2021 Earnings

Posted: Tuesday, October 19th, 2021

Estimated Reading Time: 2 minutes

Share this article on

Johnson & Johnson (NYSE:JNJ) prepares to release its Q3 2021 earnings this week. Investors expect EPS of $2.35 to be announced on the conference call, higher by 6.88% when compared to the same period last year.

Johnson & Johnson stock price is almost flat this year, up a little over 2% since the start of the trading year. However, it hovers near all-time highs, as investors still believe in the stock’s potential.

This is one of the companies that delivered a COVID-19 vaccine, and investors now await to see if a booster shot is approved. If yes, the earnings may be revised to the upside for the period ahead, with implications for the Johnson & Johnson stock price.

Johnson & Johnson is one of the leading pharmaceutical companies in the world. It has one of the biggest dividend-growth histories, as it increased its dividend for 59 consecutive years. The dividend payout ratio is 43.96%, and the dividend yield is 2.63%.

Johnson & Johnson Stock Pricce

What Are the Expectations for the Q3 2021 Earnings?

The estimates for the quarterly EPS are $2.35, higher than the same quarter last year by +6.88%. The company has delivered a positive surprise on its EPS release in the previous four quarters.

Johnson & Johnson

Analysts are optimistic when it comes to the Johnson & Johnson stock price. Out of the 28 analysts covering the stock, none has issued a sell rating, and two have neutral ratings. The rest of 26 analysts have issued buy ratings, with Credit Suisse and SVB Leering having the higher price targets of $193, respectively $200.

More articles on Stocks